{"url_path":"/sec/osrhw/8-k/2026-06-02/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1840425/0001213900-26-064037-index.html","accession_number":"0001213900-26-064037","cik":"0001840425","ticker":"OSRH","issuer_name":"OSR Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1840425/0001213900-26-064037-index.html","primary_entity_key":"0001840425","primary_entity_name":"OSR Holdings, Inc."},"word_count":344,"has_tables":true,"body_markdown":"false\n0001840425\n\n0001840425\n\n2026-05-27\n2026-05-27\n\n0001840425\n\nOSRH:CommonStockParValue0.0001PerShareMember\n\n2026-05-27\n2026-05-27\n\n0001840425\n\nOSRH:RedeemableWarrantsExercisableForSharesOfCommonStockAtExercisePriceOf11.50PerShareMember\n\n2026-05-27\n2026-05-27\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 8-K**\n\n \n\n**CURRENT REPORT**\n\n \n\n**Pursuant to Section 13 OR 15(d) of The Securities\nExchange Act of 1934**\n\n \n\nDate of Report (Date of earliest event reported):\nMay 27, 2026\n\n \n\nOSR HOLDINGS, INC.\n\n(Exact Name of Registrant as Specified in Charter)\n\n \n\nDelaware\n \n001-41390\n \n84-5052822\n\n(State or Other Jurisdiction\n \n(Commission File Number)\n \n(IRS Employer\n\nof Incorporation)\n \n \n \nIdentification No.)\n\n \n\n10900 NE 4th Street, Suite 2300, Bellevue, WA\n \n98004\n\n(Address of Principal Executive Offices)\n \n(Zip Code)\n\n \n\nRegistrant’s telephone number, including\narea code (425) 635-7700\n\n \n\nNot Applicable\n\n(Former Name or Former Address, if Changed Since Last Report)\n\n \n\nCheck the appropriate box below if the Form 8-K filing is\nintended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n☐\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n \n\n☐\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n \n\n☐\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n \n\n☐\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))\n\n \n\nSecurities registered pursuant to Section\n12(b) of the Act:\n\n \n\n**Title of each class**\n \n**Trading Symbol(s)**\n \n**Name\nof each exchange on which registered**\n\nCommon stock, par value $0.0001 per share\n \nOSRH\n \nThe Nasdaq Stock Market LLC\n\nRedeemable warrants, exercisable for shares of common stock at an exercise price of $11.50 per share\n \nOSRHW\n \nThe Nasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant is an emerging growth\ncompany as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange\nAct of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging growth company ☒\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ☐"}